Global Coronary Stent Market report delivers future development strategies, key companies, Possibility of competition, major challenges analysis. The reports elaborate the expansion rate of the Coronary Stent market supported the highest company profile analysis. This report providing an in-depth analysis, market size, and evaluation for the developing segment among the industry. Coronary Stent Market report will help you take expert decisions, recognize opportunities, plan effective professional tactics, plan new schemes, analyse drivers and restraints and give you a vision on the Coronary Stent Market forecast.
The Coronary Stent Market report discusses the primary industry growth
drivers and challenges that the vendors and the market as a whole face and
provides an overview of the key trends emerging in the market. It also talks
about the market size of different segments and their growth aspects along with
key leading countries in Americas, Asia-Pacific, Europe, the Middle East, and
Africa regions.
Get Free PDF
Sample (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size/request-sample
The Global Coronary Stent Market is predicted to reach
USD 15.18 billion by 2024 owing to factors include technological advancements,
rising load of CAD, growing number of PCI procedures (percutaneous coronary
intervention), increasing geriatric population and increasing demand for user-friendly
procedures. A coronary stent is a miniature tube that is used to open a
narrowed artery during the PCI (percutaneous coronary intervention) procedure.
This treatment comprises insertion of balloon-tipped tube in the artery which
is transported to the blockage location. The stent enlarges and forms a
platform after the balloon inflates. This helps the artery to open and
stabilize the blood flow to the heart. The Coronary stents are used in the
treatment of cardiac disorders like angina pain, myocardial infarction and
coronary artery disease. The Coronary Stent Market is expected to grow
significantly with CAGR of 6.2% in the forecast period.
The Coronary Stent prevents the heart attack that is
caused by the narrowing of coronary arteries. The stent is made of cobalt alloy
or stainless steel tube and is attached to small balloons that support to
proper blood flow and take care of the vessel wall. The coronary heart disease
treatments comprise balloon angioplasty, pharmaceuticals, stenting of coronary artery
bypass grafting. Stenting is regarded efficient for the heart patients in
comparison to the bypass heart surgery. It is free of any major operation since
it can be performed with the support of local low sedation and anesthesia.
The main driver for the growth of coronary stent industry
is the rising prevalence of heart diseases. Owing to the rising elderly
population across globe, particularly in the developed economies, the market
expects wide opportunities in the different parts of the world. Other factors
that drive the market are the genetic diseases like obesity that is prevailing
in all the age groups due to the changing unhealthy lifestyle and the
technological advancements of bio-absorbable stents.
The main reason for maximum amount of deaths caused by
the heart diseases across the globe is the CAD (Coronary artery disease).
Nevertheless, the number of Coronary Artery Disease patients has decreased due
to the increasing number of PCIs (percutaneous coronary interventions). This
procedure makes use of wide range of coronary stents which again drives the
industry growth. Besides, the expansion of BVS (bio resorb able vascular
scaffold) and the emergence of the coronary stent market offer considerable
growth opportunities. Moreover, the alternative treatment methodologies of CAD,
numerous cases of product failure and strict regulations for product approval
will restrict the market growth in the forthcoming years.
The coronary stent industry is categorized on the grounds
of product type, delivery modes, material, end-user and geographic region. On
the grounds of product type, the market is divided into drug-eluting stents,
bare-metal stents and bio absorbable stents. In the forecast period, the
drug-eluting stents section is predicted to capture maximum share of the
market. This is because the drug-eluting stents possess more benefits than the
bare-metal stents and bio absorbable stents. The benefits can be stated as
reduced risk of restenosis and other major disorders. On the grounds of
delivery modes, the coronary stent market is divided into self-expanding stents
and balloon-expanding stents. The balloon expandable stents is predicted to
capture larger market share due to the factors like increasing regulatory
approvals for balloon-expandable stents, greater use of these stents and
growing research activities to enhance technology.
Geographically, the Coronary Stents Market is divided
into Europe, North America and Asia, and the rest of the world. North America
is estimated to capture comparatively larger market share followed by Europe.
Asia is projected to capture the coronary stents industry with a good pace in
the coming years. Other factors for the growth of the market in Asia include
growing population base, prevalence of heart disease, focus of major players,
increasing adoption of modern technologies and lower manufacturing costs in the
area.
The prominent and emerging market players of coronary
stent market are Abbott Laboratories, Boston Scientific Corporation, Biosensors
International Group, Ltd., B. Braun Melsungen AG, Terumo Corporation,
Medtronic, plc, BIOTRONIK SE & Co. KG, STENTYS SA, MicroPort Scientific
Corporation, Meril Life Sciences Pvt. Ltd., Translumina GmbH, and Vascular
Concepts.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment